Previous 10 | Next 10 |
Baystreet news releases related Baystreet news releases and Baystreet press releases from 04/29/22 01:15:00 on US and Canada Markets.
U.S. stocks fell Friday with the S&P 500 on pace for the worst month since March 2020, as Amazon became the latest victim in the technology-led selloff. The Dow Jones Industrials stumbled 467.11 points, or 1.4%, to 33,449.28. The S&P 500 docked 83.45 points, or 2%, to 4,204....
U.S. stocks fell Friday with the S&P 500 on pace for the worst month since March 2020, as Amazon became the latest victim in the technology-led selloff. The Dow Jones Industrials dropped 330.4 points, or 1%, to 33,585.99. The S&P 500 slid 56.72 points, or 1.3%, to 4,230.66. ...
U.S. stock futures fell Friday morning to wrap up April trading, with the NASDAQ Composite on pace for the worst month since March 2020. Futures for the Dow Jones Industrials skidded 144 points, or 0.4%, to 33,684. Futures for the S&P 500 dropped 41.5 points, or 1%, to 4,242...
Stocks roared back Thursday, following a strong earnings report from Meta Platforms, as the market sought to recover from this month's sell-off. The Dow Jones Industrials muscled up 614.46 points, or 1.9%, to 33,916.39. The S&P 500 acquired 103.54 points, or 2.5%, to 4,287.50. ...
The Nasdaq Composite inched higher Thursday, following a strong earnings report from Meta Platforms, as the market sought to recover from this month's selloff. The Dow Jones Industrials broke for lunch Thursday up 115.74 points to 33,417.62. The S&P 500 moved up 27.72 points to ...
Stocks rose Thursday, following a strong earnings report from Meta Platforms, as the market sought to recover from this month's selloff. The Dow Jones Industrials opened Thursday up 116.09 points to 33,418.02. The S&P 500 moved up 25.29 points to 4,209.25. The NASDAQ Composi...
Cannabinoids, such as cannabidivarin (CBDV) could be a therapeutic game-changer. In fact, according to InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Eric Hsu, SVP, Pre-Clinical Research and Development for InMed commented; “Cannabinoids hold tremendous therapeutic potential t...
Cannabinoids, such as cannabidivarin (CBDV) could be a therapeutic game-changer. In fact, according to InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Eric Hsu, SVP, Pre-Clinical Research and Development for InMed commented; “Cannabinoids hold tremendous therapeutic potential t...
Cannabinoids, such as cannabidivarin (CBDV) could be a therapeutic game-changer. In fact, according to InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Eric Hsu, SVP, Pre-Clinical Research and Development for InMed commented; “Cannabinoids hold tremendous therapeutic potential t...
Cannabinoids, such as cannabidivarin (CBDV) could be a therapeutic game-changer. In fact, according to InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Eric Hsu, SVP, Pre-Clinical Research and Development for InMed commented; “Cannabinoids hold tremendous therapeutic potential t...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
38.8%Change Percent:
DexCom Inc. Company Name:
DXCM Stock Symbol:
NASDAQ Market:
dexcom.com Website: